Clinical Impact of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Carried Out for Non-Medicare Eligible Indications in Australia: A Prospective Study.
Department of Nuclear Medicine and PET, Liverpool Hospital, Australia; University of New South Wales, Sydney, Australia; University of Western Sydney, Australia.
P
P
Lin
Department of Nuclear Medicine and PET, Liverpool Hospital, Australia.
E
E
Stoakes
Department of Nuclear Medicine and PET, Liverpool Hospital, Australia.
A
A
Scott
Department of Nuclear Medicine and PET, Liverpool Hospital, Australia.
S
S
Sam
Department of Nuclear Medicine and PET, Liverpool Hospital, Australia.
A
A
Chicco
D001315:Australia; D019788:Fluorodeoxyglucose F18; D006801:Humans; D006278:Medicare / Q000706:statistics & numerical data*; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000191:economics; D049268:Positron-Emission Tomography / Q000379:methods*; D011446:Prospective Studies; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*; D014481:United States
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18